<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title><![CDATA[EC21 Product Catalogs - speaker press post]]></title>
<link><![CDATA[https://www.ec21.com/ec-market/speaker press post.html]]></link><item>
<title><![CDATA[Localization]]></title><link><![CDATA[https://willingjet.en.ec21.com/Localization--11858029_11858038.html]]></link><description><![CDATA[DRUG REGISTRATION SERVICES
Content Creation
Medical writing
Protocols for new drug Phase I-IV and re-evaluation study protol for post-marketing drug.
Other clinical study materials (Investigator&apos;s Br]]></description><pubDate><![CDATA[20231024]]></pubDate></item>

</channel>
</rss>